BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 33654266)

  • 1. Identification of genetic factors influencing metabolic dysregulation and retinal support for MacTel, a retinal disorder.
    Bonelli R; Jackson VE; Prasad A; Munro JE; Farashi S; Heeren TFC; Pontikos N; Scheppke L; Friedlander M; ; Egan CA; Allikmets R; Ansell BRE; Bahlo M
    Commun Biol; 2021 Mar; 4(1):274. PubMed ID: 33654266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic disruption of serine biosynthesis is a key driver of macular telangiectasia type 2 aetiology and progression.
    Bonelli R; Ansell BRE; Lotta L; Scerri T; Clemons TE; Leung I; ; Peto T; Bird AC; Sallo FB; Langenberg C; Bahlo M
    Genome Med; 2021 Mar; 13(1):39. PubMed ID: 33750426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide analyses identify common variants associated with macular telangiectasia type 2.
    Scerri TS; Quaglieri A; Cai C; Zernant J; Matsunami N; Baird L; Scheppke L; Bonelli R; Yannuzzi LA; Friedlander M; ; Egan CA; Fruttiger M; Leppert M; Allikmets R; Bahlo M
    Nat Genet; 2017 Apr; 49(4):559-567. PubMed ID: 28250457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. METHYLATION-ASSOCIATED PATHWAYS IN MACULAR TELANGIECTASIA TYPE 2 AND OPHTHALMOLOGIC FINDINGS IN PATIENTS WITH GENETIC METHYLATION DISORDERS.
    Pauleikhoff L; Wingert V; GrĂ¼nert SC; Lange C; Hannibal L; Bucher F
    Retina; 2024 Jun; 44(6):1052-1062. PubMed ID: 38261977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic Penetrance of Macular Telangiectasia Type 2.
    Ronquillo CC; Wegner K; Calvo CM; Bernstein PS
    JAMA Ophthalmol; 2018 Oct; 136(10):1158-1163. PubMed ID: 30098143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serine biosynthesis defect due to haploinsufficiency of PHGDH causes retinal disease.
    Eade K; Gantner ML; Hostyk JA; Nagasaki T; Giles S; Fallon R; Harkins-Perry S; Baldini M; Lim EW; Scheppke L; Dorrell MI; Cai C; Baugh EH; Wolock CJ; Wallace M; Berlow RB; Goldstein DB; Metallo CM; Friedlander M; Allikmets R
    Nat Metab; 2021 Mar; 3(3):366-377. PubMed ID: 33758422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staging of macular telangiectasia: power-Doppler optical coherence tomography and macular pigment optical density.
    Chin EK; Kim DY; Hunter AA; Pilli S; Wilson M; Zawadzki RJ; Werner JS; Park SS
    Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4459-70. PubMed ID: 23716628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinal crystals in type 2 idiopathic macular telangiectasia.
    Sallo FB; Leung I; Chung M; Wolf-Schnurrbusch UE; Dubra A; Williams DR; Clemons T; Pauleikhoff D; Bird AC; Peto T;
    Ophthalmology; 2011 Dec; 118(12):2461-7. PubMed ID: 21839520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. iPSC-derived retinal pigmented epithelial cells from patients with macular telangiectasia show decreased mitochondrial function.
    Eade KT; Ansell BRE; Giles S; Fallon R; Harkins-Perry S; Nagasaki T; Tzaridis S; Wallace M; Mills EA; Farashi S; Johnson A; Sauer L; Hart B; Diaz-Rubio ME; Bahlo M; Metallo C; Allikmets R; Gantner ML; Bernstein PS; Friedlander M
    J Clin Invest; 2023 May; 133(9):. PubMed ID: 37115691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic lipid dysregulation is a risk factor for macular neurodegenerative disease.
    Bonelli R; Woods SM; Ansell BRE; Heeren TFC; Egan CA; Khan KN; Guymer R; Trombley J; Friedlander M; Bahlo M; Fruttiger M
    Sci Rep; 2020 Jul; 10(1):12165. PubMed ID: 32699277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinal ganglion cells thinning in eyes with nonproliferative idiopathic macular telangiectasia type 2A.
    Chhablani J; Rao HB; Begum VU; Jonnadulla GB; Goud A; Barteselli G
    Invest Ophthalmol Vis Sci; 2015 Feb; 56(2):1416-22. PubMed ID: 25655800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Description of a patient cohort with Hereditary Sensory Neuropathy type 1 without retinal disease Macular Telangiectasia type 2 - implications for retinal screening in HSN1.
    Rodrigues FG; Pipis M; Heeren TFC; Fruttiger M; Gantner M; Vermeirsch S; Okada M; Friedlander M; Reilly MM; Egan C
    J Peripher Nerv Syst; 2022 Sep; 27(3):215-224. PubMed ID: 35837722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-retinal IgG antibodies in patients with early and advanced type 2 macular telangiectasia.
    McLenachan S; Balaratnasingam C; Heath Jeffery RC; Chen SC; Zhang D; Chan G; Dolz-Marco R; Bacci T; Lo J; Wiffen S; Yannuzzi LA; Chen FK
    Exp Eye Res; 2022 May; 218():109024. PubMed ID: 35271830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinal vascular layers in macular telangiectasia type 2 imaged by optical coherence tomographic angiography.
    Spaide RF; Klancnik JM; Cooney MJ
    JAMA Ophthalmol; 2015 Jan; 133(1):66-73. PubMed ID: 25317692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimodal Imaging of Macular Telangiectasia Type 2: Focus on Vascular Changes Using Optical Coherence Tomography Angiography.
    Toto L; Di Antonio L; Mastropasqua R; Mattei PA; Carpineto P; Borrelli E; Rispoli M; Lumbroso B; Mastropasqua L
    Invest Ophthalmol Vis Sci; 2016 Jul; 57(9):OCT268-76. PubMed ID: 27409482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors in patients with macular telangiectasia 2A in an Asian population: A case-control study.
    Elias A; Gopalakrishnan M; Anantharaman G
    Indian J Ophthalmol; 2017 Sep; 65(9):830-834. PubMed ID: 28905826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EARLY SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHY BIOMARKERS TO CONFIRM FELLOW EYE CHANGES IN ASYMMETRIC TYPE-2 MACULAR TELANGIECTASIA: A Case-Control Study (India Macular Telangiectasia Report 1).
    Alex D; Giridhar A; Gopalakrishnan M; Manayath G; Amar S; Raman R; Sreenivasan R; Ayachit A; Sivaprasad S
    Retina; 2021 Mar; 41(3):471-479. PubMed ID: 32804830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-retinal antibodies in patients with macular telangiectasia type 2.
    Zhu L; Shen W; Zhu M; Coorey NJ; Nguyen AP; Barthelmes D; Gillies MC
    Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5675-83. PubMed ID: 23882694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-resolution photoreceptor imaging in idiopathic macular telangiectasia type 2 using adaptive optics scanning laser ophthalmoscopy.
    Ooto S; Hangai M; Takayama K; Arakawa N; Tsujikawa A; Koizumi H; Oshima S; Yoshimura N
    Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5541-50. PubMed ID: 21642620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide association analyses identify 139 loci associated with macular thickness in the UK Biobank cohort.
    Gao XR; Huang H; Kim H
    Hum Mol Genet; 2019 Apr; 28(7):1162-1172. PubMed ID: 30535121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.